Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
one-generation reproductive toxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for type of information:
Data is from publication

Data source

Reference
Reference Type:
publication
Title:
Effects of FD & C red no. 40 on rat intrauterine development
Author:
T. F. X. COLLINS and T. N. BLACK
Year:
1980
Bibliographic source:
Food and cosmatics toxicology, Vol. 18. pp 561 to 568, 1980

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
Principles of method if other than guideline:
Embryotoxicity and teratogenicity study of FD & C RED NO. 40 in rats
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate
EC Number:
247-368-0
EC Name:
Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate
Cas Number:
25956-17-6
Molecular formula:
C18H16N2O8S2.2Na
IUPAC Name:
disodium 6-hydroxy-5-[(2-methoxy-3-methyl-4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate
Constituent 2
Reference substance name:
FD & C RED NO. 40
IUPAC Name:
FD & C RED NO. 40
Details on test material:
- Name of test material (as cited in study report): FD & C RED NO. 40 (disodium salt of 6-hydroxy-5-[(2-methoxy-5-methyl-4-sulph ophenyl)azo]-2-naphthalene sulphonic acid.)
- Molecular formula (if other than submission substance): C18H16N2O8S2.2Na
- Molecular weight (if other than submission substance): 496.4266 g/mole
- Substance type: Oragnic
- Physical state: No data available
- Impurities (identity and concentrations): 5.30% NaC1, 4.50% volatile matter,0.3 % Na2SO4 and 0.26% Schaeffer's salt (an intermediate).
Specific details on test material used for the study:
- Name of test material (as cited in study report): FD & C RED NO. 40 (disodium salt of 6-hydroxy-5-[(2-methoxy-5-methyl-4-sulph ophenyl)azo]-2-naphthalene sulphonic acid.)
- Molecular formula (if other than submission substance): C18H16N2O8S2.2Na
- Molecular weight (if other than submission substance): 496.4266 g/mole
- Substance type: Oragnic
- Physical state: No data available
- Impurities (identity and concentrations): 5.30% NaC1, 4.50% volatile matter,0.3 % Na2SO4 and 0.26% Schaeffer's salt (an intermediate).

Test animals

Species:
rat
Strain:
Osborne-Mendel
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: FDA breeding colony
- Age at study initiation: (P) x wks; (F1) x wks: No data available
- Weight at study initiation: (P) Males: x-x g; Females: x-x g; (F1) Males: x-x g; Females: x-x g: P- female – 124.1 to 134.8 g
- Fasting period before study: No data available
- Housing: Animals were housed in stainless-steel hanging cages.
- Diet (e.g. ad libitum): Purina Laboratory Chow (Ralston-Purina Co., Inc., St. Louis, MO), ad libitum
- Water (e.g. ad libitum): Distilled water, ad libitum
- Acclimation period: No data available

ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data available
- Humidity (%):No data available
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): 12 hr darkness and 12 hr light.

Administration / exposure

Route of administration:
oral: drinking water
Type of inhalation exposure (if applicable):
not specified
Vehicle:
other: Distilled water
Details on exposure:
No data available
Details on mating procedure:
- M/F ratio per cage: 1:2 ratio
- Length of cohabitation: 4.30p.m. to following morning
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy Presence of sperm in the vaginal lavage were referred to as day 0 of pregnancy
- After ... days of unsuccessful pairing replacement of first male by another male with proven fertility: No data available

- Further matings after two unsuccessful attempts: [no / yes (explain)]: No data available

- After successful mating each pregnant female was caged (how): No data available

- Any other deviations from standard protocol: Within each group a male impregnated a maximum of two females.


Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
The dye solutions were found to be stable for the duration of the experiment
Duration of treatment / exposure:
19 days
Frequency of treatment:
Daily
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/kg bw/day
Dose / conc.:
260.2 mg/kg bw/day
No. of animals per sex per dose:
Totol: 55
0 mg/kg bw/day: 30
260.2 mg/kg bw/day: 25
Control animals:
yes, concurrent vehicle

Examinations

Parental animals: Observations and examinations:
Clinical signs , Body weight, water consumption were examihned.
Oestrous cyclicity (parental animals):
Any irregularity in Estrous cyclicity were examined.

Presence and location of resorption sites and implantation sites Corpora lutea were examined.
Sperm parameters (parental animals):
No data available
Litter observations:
Live and dead foetuses, weight and sexed were examined.
Postmortem examinations (parental animals):
No data available
Postmortem examinations (offspring):
Gross external malformationsunder magnification, and the crown-rump length and soft tissues variations was measured.
Statistics:
Statistical analysis were performed by using a least significant difference (LSD) test for numbers of corpora lutea per dam, implantations per dam, numbers of viable implants per dam, foetal body weights and crown-rump lengths. Freeman-Tukey arc-sine transformation for binomial proportions (Mosteller & Youtz, 1961) followed by an analysis of variance and an LSD test used for The number of resorptions per litter and the average number of foetuses with one or more variations per litter. Preimplantation loss data were transformed using the Freeman-Tukey arc-sine transformation followed by an analysis of variance and an LSD test. The numbers of litters with one or more resorptions, one or more skeletal or soft tissue variations and specific external, soft-tissue and skeletal variations were analysed by Fisher's exact one-tail test (Siegel, 1956). An analysis of variance was used to test maternal weight gain. An Armitage lest for linearity of proportions (Armitage, 1973) was also used to detect trends. Differences in water consumption were analysed by a paired t-test.
Reproductive indices:
No data available
Offspring viability indices:
No data available

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
no effects observed
Description (incidence and severity):
No external signs of toxicity and animals appeared healthy and behaved normally in treated groups as compared to control.
Dermal irritation (if dermal study):
not specified
Mortality:
not specified
Body weight and weight changes:
no effects observed
Description (incidence and severity):
No effect on maternal weight gain was observed in treated groups as compared to control.
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
effects observed, treatment-related
Description (incidence and severity):
Significant decrease in water consumption was observed in treated rats as compare to control.
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
not specified
Behaviour (functional findings):
not specified
Immunological findings:
not specified
Organ weight findings including organ / body weight ratios:
not specified
Histopathological findings: non-neoplastic:
not specified
Histopathological findings: neoplastic:
not specified
Other effects:
not specified

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
no effects observed
Description (incidence and severity):
No significant changes in or treatment-related effects on the numbers of corpora lutea, implantations, early and late deaths and viable foetuses per litter or on the percentage of preimplantation loss were observed in treated group as compared to control.
Reproductive function: sperm measures:
not specified
Reproductive performance:
no effects observed
Description (incidence and severity):
No significant effect on percentage of early resorptions and percentage of females with more than one and with more than two resorptions were observed in treated rats as compared to control.

Effect levels (P0)

Dose descriptor:
NOAEL
Effect level:
260.2 mg/kg bw/day
Based on:
test mat.
Sex:
female
Basis for effect level:
clinical signs
body weight and weight gain
reproductive function (oestrous cycle)
reproductive performance
Remarks on result:
other: No effect observed

Target system / organ toxicity (P0)

Critical effects observed:
not specified
System:
other: not specified
Organ:
not specified
Treatment related:
not specified
Dose response relationship:
not specified
Relevant for humans:
not specified

Results: F1 generation

General toxicity (F1)

Clinical signs:
not specified
Dermal irritation (if dermal study):
not specified
Mortality / viability:
no mortality observed
Description (incidence and severity):
No effect on live or dead fetuses was observed in treated dose groups as compared to control.
Body weight and weight changes:
no effects observed
Description (incidence and severity):
No effect on mean fetal body weight was observed in treated groups as compared to control.
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
not specified
Sexual maturation:
not specified
Organ weight findings including organ / body weight ratios:
not specified
Gross pathological findings:
no effects observed
Description (incidence and severity):
When treated with 260.2 mg/kg bw/day, No treatment related external variations were observed in litters of treated dams as compared to control.

Number of runts: Increase in number of runts was observed in litters of treated rats as compared to control.
Histopathological findings:
no effects observed
Description (incidence and severity):
Soft-tissue variations: slight increase in number of affected litters was observed in 260.2 mg/kg bw/day treated rats as compared to control.

Skeletal variations:
Slight increase in the number of bipartite sternebrae and reduced ossification of the parietal bone were observed in litters of treated dams as compared to control.
The observed increases did not appear to be dose-related.
Other effects:
no effects observed
Description (incidence and severity):
Crown-rump length: No effect on Crown-rump length were observed in litters of treated dams as compared to control.

Sex distribution: No effect on Sex distribution were observed in litters of treated dams as compared to control.

Developmental neurotoxicity (F1)

Behaviour (functional findings):
not specified

Developmental immunotoxicity (F1)

Developmental immunotoxicity:
not specified

Effect levels (F1)

Dose descriptor:
NOAEL
Generation:
F1
Effect level:
260.2 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
mortality
body weight and weight gain
gross pathology
histopathology: non-neoplastic
Remarks on result:
other: No effect on Live and dead foetuses, weight, sex, gross pathology and histopathiology

Target system / organ toxicity (F1)

Critical effects observed:
not specified
System:
other: not specified
Organ:
not specified
Treatment related:
not specified
Dose response relationship:
not specified
Relevant for humans:
not specified

Overall reproductive toxicity

Reproductive effects observed:
not specified
Treatment related:
not specified
Relation to other toxic effects:
not specified
Dose response relationship:
not specified
Relevant for humans:
not specified

Any other information on results incl. tables

Maternal and reproductive data for rats given FD & C red no 40 during gestation

 

 

 

Autopsy finding (mean/dam)

 

 

Females with Resorption (%)

 

 

 

 

 

Resorption

 

 

 

One or more

Two or more

Mode of addministration and dose level

no. Of pregnant females examined

mean maternal body weigh tgain (g)*

Corpora lutea*

implantations*

Early

Late

Viable foetuses*

Resorption (%)

Preimplantation

 

 

Intubation (%)

 

 

 

 

 

 

 

 

 

 

 

0

30

147.0 ± 3.6

13.4 ± 0.4

12.0 ± 0.5

0.5

0

11.5±0.5

4.4

10.4

43.3

10.0

0.2

25

147.5 ± 4.1

13.6 ± 0.3

12.7 ± 0.3

0.6

0

12.0±0.3

5.0

7.0

48.0

16.0

*Values are means ± SEM.

 Incidence of specifice external and soft tissue variations of foetuses of rats given FD & C red no 40 during gestation

 

 

Incidence* in foetuses and litters of rats administered FD & C red no 40

 

 

In the drinking water

Variation

Dose level†

0

0.2

 

 

External examinations

No. Examined

 

345 (30)

301 (25)

Runt

 

1 (1)

4 (4)

Oedema

 

2 (1)

 

Cranial pimple

 

1 (1)

 

Exencephaly 

 

1 (1)

 

 

 

Soft tissue examination

No. Examined

 

180 (30)

161 (25)

Hydrourter: moderate

 

7 (5)

7 (5)

sever

 

1 (1)

1 (1)

Hydronephrosis: moderate

 

8 (4)

6 ()5

sever

 

1 (1)

1 (1)

Ectopic kidney

 

2 (2)

1 (1)

Pitted kidney

 

1 (1)

1 (1)

Deformed kidney

 

1 (1)

 

Haemorrhage

 

13 (8)

8 (7)

Hydrocephalus

 

2 (1)

1 (1)

Microphthalmia

 

1 (1)

 

oesophageal pouch

 

1 (1)

 

* No. Of foetuses affected and in parentheses, no of litters.

†The dose level is expressed as mg/kg/day as a percentage in the drinking water

Incidence of soft – tissue variations in foetusees of rats given FD & C red no 40 during gestation

 

Soft tissue variations

Foetuses with one or more Soft tissue variations

Litters with one or more foetuses with variations

Drinking water (%)

Total

Mean/litter

No.

Mean/litter

% of total foetuses

No.

% of total litters

0

37

1.2

28

0.9

15.6

13

43.3

0.2

25

1.0

17

0.7

10.6

14

56.0

 

Incidence of sternebral variations in foetusees of rats given FD & C red no 40 during gestation

 

Soft tissue variations

Foetuses with one or more Soft tissue variations

Litters with one or more foetuses with variations

Drinking water (%)

Total

Mean/litter

No.

Mean/litter

% of total foetuses

No.

% of total litters

0

57

1.9

49

1.6

30.2

22

73.3

0.2

58

2.3

52

2.1

37.1

20

80.0

 

Incidence of Skeletal variations in foetusees of rats given FD & C red no 40 during gestation

 

Soft tissue variations

Foetuses with one or more Soft tissue variations

Litters with one or more foetuses with variations

Drinking water (%)

Total

Mean/litter

No.

Mean/litter

% of total foetuses

No.

% of total litters

0

56

1.9

42

1.4

25.9

21

70.0

0.2

58

2.3

31

1.2

22.1

14

56.0

Applicant's summary and conclusion

Conclusions:
NOAEL was considered to be 260.2 mg/kg body weight /day for F0 and F1 generation when Osborne-Mendel female rats were treated wtih FD & C RED NO. 40.
Executive summary:

In a Embryotoxicity and teratogenicity study, Osborne-Mendel female rats were treated with FD & C RED NO. 40 in the concentration of 260.2 mg/kg body weight /day in distilled water by oral drinking water. No external signs of toxicity and animals were appeared healthy and behaved normally in treated groups as compared to control. No effects on maternal weight gain and significant decrease in water consumption were observed in treated female rats as compared to control. No significant effects on numbers of corpora lutea, implantations, early and late deaths and viable foetuses per litter or on the percentage of preimplantation loss were observed in treated group as compared to control. Similarly, no significant effect on percentage of early resorptions and percentage of females with more than one and with more than two resorptions were observed in treated rats as compared to control. In addition, No effect on live or dead fetuses and mean fetal body weight and percentage of males and females per treatment group were observed as compared to control. Increase in number of runts was observed in litters, but no external variations were observed in litters of treated dams as compared to control. No effect on Crown-rump length and Sex distribution were observed in litters of treated dams as compared to control. Slight increase in number of affected litters, number of bipartite sternebrae and reduced ossification of the parietal bone were observed in litters of treated dams as compared to control. But, the observed increases did not appear to be dose-related. Therefore, NOAEL was considered to be 260.2mg/kg body weight /day for F0 and F1 generation when Osborne-Mendel female rats were treated with FD & C RED NO. 40. orally in Drinking water for 19 days.